0001209191-16-152311.txt : 20161129 0001209191-16-152311.hdr.sgml : 20161129 20161129165432 ACCESSION NUMBER: 0001209191-16-152311 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161129 DATE AS OF CHANGE: 20161129 EFFECTIVENESS DATE: 20161129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hydropothecary Corp CENTRAL INDEX KEY: 0001690947 IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-275268 FILM NUMBER: 162023275 BUSINESS ADDRESS: STREET 1: 120 CHEMIN DE LA RIVE CITY: GATINEAU STATE: A8 ZIP: J8M 1V2 BUSINESS PHONE: 1-844-406-1852 MAIL ADDRESS: STREET 1: 120 CHEMIN DE LA RIVE CITY: GATINEAU STATE: A8 ZIP: J8M 1V2 D/A 1 primary_doc.xml X0707 D/A LIVE 0001690947 Hydropothecary Corp 120 Chemin de la Rive Gatineau A8 QUEBEC, CANADA J8M 1V2 1-844-406-1852 QUEBEC, CANADA None None Corporation true 2013 Sebastien Georges St. Louis 120 Chemin de la Rive Gatineau A8 QUEBEC, CANADA J8M 1V2 Executive Officer Director Mr. St. Louis is the Chief Executive Officer and a director of the Issuer. Ed Chaplin 120 Chemin de la Rive Gatineau A8 QUEBEC, CANADA J8M 1V2 Executive Officer Mr. Chaplin is Chief Financial Officer of the Issuer. Vincent Chiara 120 Chemin de la Rive Gatineau A8 QUEBEC, CANADA J8M 1V2 Director Jason Ewart 120 Chemin de la Rive Gatineau A8 QUEBEC, CANADA J8M 1V2 Director Michael Munzar 120 Chemin de la Rive Gatineau A8 QUEBEC, CANADA J8M 1V2 Director Adam Gaston Miron 120 Chemin de la Rive Gatineau A8 QUEBEC, CANADA J8M 1V2 Executive Officer Director Mr. Miron is the Chief Brand Officer and a director of the Issuer. Pharmaceuticals Decline to Disclose 06b true 0001209191-16-152271 2016-11-14 false true true false 50000 AXIOM CAPITAL MANAGEMENT, INC. 26580 None None 780 THIRD AVENUE, 43RD FLOOR NEW YORK NY NEW YORK 10017-2024 CA CALIFORNIA FL FLORIDA HI HAWAII IL ILLINOIS MI MICHIGAN NY NEW YORK TX TEXAS 10231000 3275000 6956000 false 24 289013 0 Axiom Capital Management, Inc. was paid a commission/placement agents fee of US$289,013 and 62,381 agents common share purchase warrants, each exercisable to acquire one common share at a price of US$4.60 per share for a period of three years. 0 false Hydropothecary Corp Ed Chaplin /s/ Ed Chaplin Chief Financial Officer 2016-11-28